Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Devices not on FDA's agenda for MRA (mutual recognition agreement) meeting:

This article was originally published in Clinica

Executive Summary

The FDA's first public meeting to discuss progress in implementing the mutual recognition agreement (MRA) between the US and the European Union will focus on the agreement as it relates to pharmaceuticals, and not medical devices. The agency initially wanted to discuss the medical device sectoral annex and the drugs sectoral annex of the accord at its December 8 meeting but changed its mind because of differences between the two, according to Charles Gaylord in the FDA office of international and constituent relations. No date has been set for a public meeting on the section of the agreement covering devices, but it will probably take place within a few months, he said.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079860

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel